Logo Logo Logo Logo Logo
  • Home
  • About
  • Resources
  • Sites
  • Tracker
  • News
    • Press releases
    • Stories
    • In the media
  • Contact
  • Home
  • About
  • Resources
  • Sites
  • Tracker
  • News
    • Press releases
    • Stories
    • In the media
  • Contact

In the media

Home > In the media

Devex – “Pan-African platform aims to hasten clinical trials”

7 March 2023

Nature – “The hunt for drugs for mild COVID: scientists seek to treat those at lower risk”

18 July 2022

Salon- “Rollout of new effective COVID pill mirrors the “injustice of vaccine apartheid” in poor countries”

26 April 2022

Libération – “Nouveaux traitements contre le Covid: «Il faut rester vigilants et être prêts, ce qui n’est pas encore le cas»”

11 April 2022

Nature- “African clinical trial denied access to key COVID drug Paxlovid”

4 April 2022

Agence Congolaise de Presse – “Covid-19 : Pfizer bloque les recherches sur l’utilisation de son nouveau médicament antiviral dans les pays à revenu faible”

17 March 2022

British Medical Journal – “Covid-19: Campaigners accuse Pfizer of blocking access to antiviral for trials in poorer countries”

Actualité CD – “Covid-19 en Afrique : pour l’étude Anticov, la nouvelle association thérapeutique ne réduit pas le risque d’hospitalisation chez les patients atteints d’une forme légère à modérée”

Nation Africa – “Researchers fault Pfizer for non-cooperation on its Covid pill”

16 March 2022

Politico – “Research group claims Pfizer is blocking studies on its COVID pill”

15 March 2022
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
DNDi
Contact us

anticov@dndi.org

  • Home
  • About
  • Resources
  • Sites
  • Tracker
  • News
  • Contact
  • Terms of Use
  • Acceptable Use Policy
  • Privacy Policy
  • Cookie Policy

Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License